TELESIS BIO (TBIO)
(Delayed Data from NSDQ)
$3.45 USD
-0.09 (-2.54%)
Updated May 24, 2024 03:59 PM ET
After-Market: $3.54 +0.09 (2.61%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
[TBIO]
Reports for Purchase
Showing records 21 - 40 ( 108 total )
Industry: Medical - Drugs
Q121: Phase I/II COVID-19 mRNA Vaccine Interim Readout in 3Q21
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
mRNA Utility in Cystic Fibrosis Unclear. Lowering PT to $28.
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Interim MRT5005 Data Leaves Us Wanting More, As Pipeline Advances On; PT to $28
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Drugs
Industry: Medical - Drugs
MRT5005 CF Data in Near-Term, Met With Sanofi Collaboration Progress in 2021
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
COVID-19 mRNA Vaccine Trial To Begin in March as Expected
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
MAD Data in Cystic Fibrosis Patients Expected in Q221
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Industry: Medical - Drugs
Valuation Change Through A Vaccine Lens. Raising PT to $37.
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Join Our COVID Vaccine Manufacturing & Supply Chain Webinar Today at 2PM ET
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Join Our COVID Vaccine Manufacturing/Supply Chain Webinar on December 15th at 2PM ET
Provider: Roth Capital Partners, Inc.
Analyst: BUTLER T
Industry: Medical - Drugs
Industry: Medical - Drugs
Sanofi Collaboration Leads MRT5500 Towards Clinic, Expected 1Q21
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A